Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 1/1999

01-02-1999

A prospective multicenter trial evaluating diagnostic validity of multivariate analysis and individual serum marker in differential diagnosis of pancreatic cancer from benign pancreatic diseases

Authors: Tetsuo Hayakawa, Satoru Naruse, Motoji Kitagawa, Hiroshi Ishiguro, Takaharu Kondo, Kumiko Kurimoto, Masanori Fukushima, Tetsuo Takayama, Yuji Horiguchi, Nobuyoshi Kuno, Aiji Noda, Toshiyuki Furukawa

Published in: Journal of Gastrointestinal Cancer | Issue 1/1999

Login to get access
Metadata
Title
A prospective multicenter trial evaluating diagnostic validity of multivariate analysis and individual serum marker in differential diagnosis of pancreatic cancer from benign pancreatic diseases
Authors
Tetsuo Hayakawa
Satoru Naruse
Motoji Kitagawa
Hiroshi Ishiguro
Takaharu Kondo
Kumiko Kurimoto
Masanori Fukushima
Tetsuo Takayama
Yuji Horiguchi
Nobuyoshi Kuno
Aiji Noda
Toshiyuki Furukawa
Publication date
01-02-1999
Publisher
Humana Press
Published in
Journal of Gastrointestinal Cancer / Issue 1/1999
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1385/IJGC:25:1:23

Other articles of this Issue 1/1999

Journal of Gastrointestinal Cancer 1/1999 Go to the issue

OriginalPaper

Perioperative hepatic functional risk assessed with technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin liver scintigraphy in patients undergoing pancreaticoduodenectomy complicated by obstructive jaundice

OriginalPaper

Change in editorship

OriginalPaper

Molecular forms of serum pancreatic stone protein in acute pancreatitis

Case Report

Intrapancreatic accessory spleen

BookReview

Book review

Letter To The Editor

Fecal weight determination can unfortunately not replace unpopular and costly fecal fat estimation in the diagnosis of steatorrhea
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits